Skip to main
CCRN

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 80%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare is expected to continue to face near-term challenges as the healthcare staffing industry experiences post-pandemic normalization; however, the company is well-positioned for long-term growth due to its strategic pivot towards technology-driven solutions, exemplified by the recent acquisition offer from Knox Lane. The company has experienced revenue growth even during the pandemic, demonstrating its resilience and potential for further expansion as the healthcare industry faces ongoing workforce issues. Additionally, with a strong balance sheet and the leadership of CEO Kevin Clark, who has a successful track record in both healthcare staffing and technology companies, Cross Country is poised to capitalize on increased technology adoption and potential AI innovation, potentially leading to significant upside for investors.

Bears say

Cross Country Healthcare is facing challenges in the healthcare staffing industry due to pricing pressure, performance concerns, and the recent CEO transition. The company's potential for growth through technology-based staffing and expansion into other sectors is hindered by the lack of successful execution and competition. The recent termination of the merger agreement with Aya and payment of a $20 million fee highlights potential financial struggles and market share decline. Regulatory concerns surrounding their Intellify strategy also pose potential challenges for their MSP/VMS businesses.

CCRN has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 5 analysts, CCRN has a Hold consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.